Evonik Reaches Milestone With Permanently Implantable VESTAKEEP® PEEK

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J.--(BUSINESS WIRE)--Evonik Corporation said today each of its primary implantable VESTAKEEP® PEEK product lines have been referenced in customer products that have received U.S. Food and Drug Administration’s (FDA) 510(k) clearance for permanent implant use.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC